Victoria J. Sinibaldi

2.6k total citations
57 papers, 2.0k citations indexed

About

Victoria J. Sinibaldi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Victoria J. Sinibaldi has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Victoria J. Sinibaldi's work include Prostate Cancer Treatment and Research (30 papers), Renal cell carcinoma treatment (15 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). Victoria J. Sinibaldi is often cited by papers focused on Prostate Cancer Treatment and Research (30 papers), Renal cell carcinoma treatment (15 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). Victoria J. Sinibaldi collaborates with scholars based in United States, Israel and South Korea. Victoria J. Sinibaldi's co-authors include Mario A. Eisenberger, Michael A. Carducci, Menachem Laufer, Samuel R. Denmeade, Merrill J. Egorin, Leonard Reyno, Marianna Zahurak, Eleanor G. Zuhowski, Ross C. Donehower and Роберто Пили and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Brain.

In The Last Decade

Victoria J. Sinibaldi

55 papers receiving 1.9k citations

Peers

Countries citing papers authored by Victoria J. Sinibaldi

Since Specialization

Citations

This map shows the geographic impact of Victoria J. Sinibaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria J. Sinibaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria J. Sinibaldi more than expected).

Fields of papers citing papers by Victoria J. Sinibaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria J. Sinibaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria J. Sinibaldi. The network helps show where Victoria J. Sinibaldi may publish in the future.

Co-authorship network of co-authors of Victoria J. Sinibaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria J. Sinibaldi. A scholar is included among the top collaborators of Victoria J. Sinibaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria J. Sinibaldi. Victoria J. Sinibaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abscopal effect following checkpoint inhibitor therapy and localized radiotherapy for metastatic clear cell renal cell carcinoma: A case report 2024 ·Urology Case Reports ·(unknown), Evan Fox, Victoria J. Sinibaldi, Lawrence Kleinberg, Yasser Ged	0
2	Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy 2020 ·European Journal of Cancer ·Laura A. Sena, Hao Wang, Su Jin Lim, (unknown), (unknown), John T. Isaacs, Jun Luo, (unknown), Victoria J. Sinibaldi, Michael A. Carducci, Channing J. Paller, Mario A. Eisenberger, Mark C. Markowski, Emmanuel S. Antonarakis, Samuel R. Denmeade	31
3	Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study 2017 ·The Lancet Oncology ·Benjamin A. Teply, Hao Wang, Brandon Luber, Rana Sullivan, (unknown), Ashley Bruns, Avery Spitz, (unknown), Victoria J. Sinibaldi, (unknown), Changxue Lu, John L. Silberstein, Jun Luo, Michael T. Schweizer, Charles G. Drake, Michael A. Carducci, Channing J. Paller, Emmanuel S. Antonarakis, Mario A. Eisenberger, Samuel R. Denmeade	137
4	Outcome of patients with metastatic chromophobe renal cell carcinoma treated with sunitinib 2016 ·Annals of Oncology ·Victoria Neiman, Daniel Keizman, David Sarid, J.-L. Lee, Avishay Sella, Maya Gottfried, (unknown), Mario A. Eisenberger, Michael A. Carducci, Victoria J. Sinibaldi, Eli Rosenbaum, (unknown), Avivit Neumann, Wilmosh Mermershtain, Keren Rouvinov, Raanan Berger, İbrahim Yıldız	0
5	Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma 2016 ·Clinical Genitourinary Cancer ·Daniel Keizman, Maya Ish‐Shalom, Avishay Sella, Maya Gottfried, (unknown), Avivit Peer, Hans J. Hammers, Mario A. Eisenberger, Victoria J. Sinibaldi, Victoria Neiman, Eli Rosenbaum, David Sarid, Wilmosh Mermershtain, Keren Rouvinov, Raanan Berger, Michael A. Carducci	17
6	Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib? 2015 ·Cancer Research and Treatment ·Daniel Keizman, Keren Rouvinov, Avishay Sella, Maya Gottfried, (unknown), Jaeyeon Kim, Mario A. Eisenberger, Victoria J. Sinibaldi, Avivit Peer, Michael A. Carducci, Wilmosh Mermershtain, Raya Leibowitz‐Amit, Rony Weitzen, Raanan Berger	8
7	Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor‐directed therapies 2015 ·The Prostate ·Rosa Nadal, Hua‐Ling Tsai, Victoria J. Sinibaldi, Channing J. Paller, Emmanuel S. Antonarakis, (unknown), Michael A. Carducci, Mario A. Eisenberger	16
8	Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma 2012 ·European Journal of Cancer ·Daniel Keizman, Maya Ish‐Shalom, Роберто Пили, Hans J. Hammers, Mario A. Eisenberger, Victoria J. Sinibaldi, Ben Boursi, (unknown), Maya Gottfried, (unknown), Avivit Peer, Svetlana Kovel, Avishay Sella, Raanan Berger, Michael A. Carducci	42
9	The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen Deprivation 2011 ·The Prostate ·Daniel Keizman, Peng Huang, Emmanuel S. Antonarakis, Victoria J. Sinibaldi, Michael A. Carducci, Samuel R. Denmeade, Jaeyeon Kim, J Walczak, Mario A. Eisenberger	24
10	Docetaxel treatment in the elderly patient with hormone refractory prostate cancer 2008 ·Clinical Interventions in Aging ·Victoria J. Sinibaldi	9
11	A Phase II Trial of Temozolomide and IFN- α in Patients with Advanced Renal Cell Carcinoma 2004 ·Journal of Interferon & Cytokine Research ·(unknown), J Walczak, (unknown), Theresa Rogers, Mario A. Eisenberger, Samuel R. Denmeade, Роберто Пили, Carol Ann Huff, Victoria J. Sinibaldi, Michael A. Carducci	7
12	Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of action 2004 ·Urology ·Mario A. Eisenberger, Menachem Laufer, Nicholas J. Vogelzang, Oliver Sartor, Donald Thornton, Blake Lee Neubauer, Victoria J. Sinibaldi, Gary Lieskovsky, Michael A. Carducci, Mariana L. Zahurak, Derek Raghavan	14
13	Phase II evaluation of docetaxel plus one‐day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma 2002 ·Cancer ·Victoria J. Sinibaldi, Michael A. Carducci, (unknown), Menachem Laufer, Marianna Zahurak, Mario A. Eisenberger	122
14	Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer 1999 ·Urology ·Menachem Laufer, Victoria J. Sinibaldi, Michael A. Carducci, Mario A. Eisenberger	6
15	A prospective study of suramin-induced peripheral neuropathy 1996 ·Brain ·Vinay Chaudhry, Mario A. Eisenberger, Victoria J. Sinibaldi, Khadija Sheikh, Justin W. Griffin, David R. Cornblath	72
16	Ocular Symptoms and Signs Associated With Suramin Sodium Treatment for Metastatic Cancer of the Prostate 1996 ·American Journal of Ophthalmology ·(unknown), Victoria J. Sinibaldi, Mario A. Eisenberger	10
17	Combined Carboplatin Plus Bleomycin and Conventional Radiotherapy for Advanced Carcinomas of the Head and Neck 1995 ·American Journal of Clinical Oncology ·(unknown), Mohan Suntharalingam, Mario A. Eisenberger, Victoria J. Sinibaldi, Omar M. Salazar	5
18	Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer. 1994 ·Journal of Clinical Oncology ·Duncan I. Jodrell, Leonard Reyno, R. Sridhara, Mario A. Eisenberger, Katherine H. R. Tkaczuk, Eleanor G. Zuhowski, Victoria J. Sinibaldi, Matjaž Novak, Merrill J. Egorin	42
19	Approaches to optimal dosing of hexamethylene bisacetamide 1992 ·Cancer Chemotherapy and Pharmacology ·Barbara A. Conley, Merrill J. Egorin, Victoria J. Sinibaldi, (unknown), (unknown), (unknown), Eleanor G. Zuhowski, Alan Forrest, David A. Van Echo	17
20	Carboplatin in the treatment of squamous cell head and neck cancers. 1992 ·PubMed ·Joseph Aisner, Victoria J. Sinibaldi, Mario A. Eisenberger	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact